Nicole Bort, NP
Nurse Practitioner · Brunswick, OHNPI 1811368053
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $21,731 of the $32,978 with a category attached, or 65.9%. 14 manufacturers reported payments, led by AbbVie at 46.9% of the total. Among nurse practitioner clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 271 payments — averaging $121.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$15K
- Galderma Laboratories, L.p.$11K
- Eli Lilly$2K
- Regeneron Healthcare Solutions, Inc.$2K
- E.r. Squibb & Sons, L.L.C.$496
- Novartis$425
- plus $2K from 8 others
What the payments were for
- Consulting fees$3,76811%
- Speaking & faculty fees$21,73166%
- Travel & lodging$1,7855%
- Food & beverage$5,19616%
- Education$4982%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 116 | $15,463 |
| Galderma Laboratories, L.p. | 31 | $11,496 |
| Eli Lilly | 3 | $1,939 |
| Regeneron Healthcare Solutions, Inc. | 13 | $1,617 |
| E.r. Squibb & Sons, L.L.C. | 25 | $496 |
| Novartis | 25 | $425 |
| Johnson & Johnson | 14 | $393 |
| Sun Pharmaceutical Industries Inc. | 8 | $313 |
| Lilly USA, LLC | 8 | $271 |
| UCB, Inc. | 13 | $262 |
| Sanofi | 7 | $140 |
| Boehringer Ingelheim | 4 | $116 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $25 |
| Organon | 3 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$32,978 in reported general payments places this provider in the 95th percentile of 4,700 nurse practitioner providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 13 | $259,739 |
| OtezlaApremilast | 26 | $127,207 |
| Humira(Cf) PenAdalimumab | 15 | $103,240 |
| Dupixent PenDupilumab | 25 | $93,945 |
| Taltz AutoinjectorIxekizumab | 12 | $81,329 |
| Dupixent SyringeDupilumab | 13 | $48,160 |
| Clobetasol Propionate | 107 | $4,670 |
| Ketoconazole | 198 | $3,692 |
| Tacrolimus | 11 | $2,108 |
| Doxycycline Hyclate | 50 | $1,664 |
| Clindamycin Phosphate | 38 | $1,639 |
| Metronidazole | 25 | $1,525 |
| Fluorouracil | 16 | $1,326 |
| Triamcinolone Acetonide | 132 | $726 |
| ValacyclovirValacyclovir Hcl | 17 | $530 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Brunswick
- Margaret BobonichCleveland$235K
- Mary GallagherWestlake$229K
- Sonia HissettCincinnati$179K
- Ashley TaylorNew Albany$107K
- Beth FaimanCleveland$101K
- Katherine AlexanderColumbus$99K
- Tiffany JonesCincinnati$99K
- Kate NewmanWestlake$78K
- Daniella GerySouth Euclid$73K
- Amy HazelCanton$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.